Drug · DIN 02238673
GABAPENTIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 25, 2017.
- Drug Identification Number (DIN)
- 02238673
- Company (DIN owner)
- Omni Laboratories Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 400 MG | CAP |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 26, 1998: NOC 2935New Drug Submission (NDS)
Other DINs named GABAPENTIN
- DIN 02246314 · Marketed
- DIN 02246315 · Marketed
- DIN 02246316 · Marketed
- DIN 02353245 · Marketed
- DIN 02353253 · Marketed
- DIN 02353261 · Marketed
- DIN 02388200 · Marketed
- DIN 02388219 · Marketed
- DIN 02431289 · Marketed
- DIN 02432072 · Marketed
- DIN 02432080 · Marketed
- DIN 02238671 · Cancelled Pre Market
- DIN 02238672 · Cancelled Pre Market
- DIN 02273853 · Cancelled Post Market
- DIN 02304775 · Cancelled Post Market
- DIN 02304783 · Cancelled Post Market
- DIN 02304791 · Cancelled Post Market
- DIN 02342650 · Cancelled Pre Market
- DIN 02342669 · Cancelled Pre Market
- DIN 02342677 · Cancelled Pre Market